Transformative arrival of oral weight loss medicines in the US
The arrival of the oral appetite suppressant drug Wegovy across 70,000 US pharmacies offers a more affordable and convenient weight-loss…
Pricing and Market Access
US comes up with two mandatory IRP use pricing models under Trump’s MFN strategy
China releases 2025 NRDL and first commercial insurance drug list
Win for pharma in UK – zero US tariffs, VPAG rate cap and NICE threshold increase
Slow progress as rare disease regulations in developing ASEAN states begin to take shape
Sri Lanka’s drug pricing reform: balancing affordability with sustainability
The threshold debate in Norway
Trump administration announces MFN drug pricing deal with Pfizer
